|49.06|| +0.37 / +0.76%|
Orthofix International NV engages in the research, development, and market of orthopedic solutions. It operates through the following business segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology. The Biologics segment includes regenerative products. The Extremity Fixation segment manufactures and distributes orthopedic products for fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment develops and sells implant products for spine surgeries. The company was founded on October 19, 1987 and is headquartered in Willemstad, Netherlands.
|Bradley R. Mason||President, CEO & Executive Director|
|Douglas C. Rice||Chief Financial & Accounting Officer|
|James T. Ryaby||Chief Scientific Officer|
|Jill Mason||Chief Ethics & Compliance Officer|
|Michael M. Finegan||Chief Strategy Officer|